Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Lanova Medicines Zhejiang Co., Ltd.

Clinical trials sponsored by Lanova Medicines Zhejiang Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New hope for advanced stomach cancer: experimental drug LM-302 enters final testing phase Results expected Nov 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New drug cocktail aims to shrink Hard-to-Treat GI tumors

Disease control Recruiting now

This phase 2 trial tests a new drug called LM-302 combined with other cancer treatments in people with advanced gastrointestinal cancers that have a specific marker (CLDN18.2). The study aims to see if the combination can slow tumor growth or shrink tumors. About 276 participants…

Phase 2 • Sponsor: LaNova Medicines Zhejiang Co., Ltd. • Aim: Disease control

Last updated Jun 26, 2026 16:47 UTC